Sort
82,697 grants matching “vaccine development”
Evolution of T cell immunity in blood and tissues over childhood
$807,646Donna L Farber · Columbia University Health Sciences · U01 · FY2023 · AI
SHIV-guided design of novel HIV-1 fusion peptide immunogens
$807,628George M Shaw · University Of Pennsylvania · R01 · FY2024 · AI
Development of a Self Inactivating, Highly Effective TB Vaccine
$807,595Joanne L. Flynn · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · AI
Cervical, Anal, and Oral HPV Persistence and Risk Factors Among Adolescent Girls
$807,540Angela Diaz · Icahn School Of Medicine At Mount Sinai · R01 · FY2010 · AI
Host Immune Responses to Antigens of Malaria Parasites
$807,519Carole Long · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Structural definition of CD4-induced HIV-1 Env conformational changes required for infection
$807,497Priyamvada Acharya · Duke University · R01 · FY2025 · AI
Development of mRNA-platform vaccines
$807,427Fredrick Heath Damron · West Virginia University · R01 · FY2025 · AI
Establishing ferret models to optimize new influenza vaccines that replace original antigenic sin with initial blessings of induced immunity
$807,420Scott Eric Hensley · University Of Pennsylvania · R56 · FY2020 · AI
Safety Studies for Clinical Trials of a Botanical Drug for Sickle Cell Disease
$807,410Robert Swift · Invenux, Llc · R44 · FY2016 · HL
Targeting IgM Memory to Establish Protective B Cell Responses to HIV
$807,376James J Kobie · University Of Rochester · R01 · FY2017 · AI
Temporal Phenotypes and Risk Models for the Post-COVID Syndrome and its sub-types
$807,376Hossein Estiri · Massachusetts General Hospital · R01 · FY2025 · AI
Potent Antibody Protection Against P. falciparum and P. vivax Malaria
$807,330Brandon James Dekosky · Massachusetts General Hospital · R01 · FY2025 · AI
Characterization of CAR-directed T-cells to suppress HIV-1 in vivo
$807,216Scott G Kitchen · University Of California Los Angeles · U19 · FY2019 · AI
Experimental Gonococcal Vaccine
$807,210Dominick Auci · Therapyx, Inc. · R44 · FY2020 · AI
Skin microbiome contributions to the pathogenesis of cutaneous leishmaniasis
$807,175Phillip A. Scott · University Of Pennsylvania · R01 · FY2024 · AI
Assembly of MHC Class I Molecules in Vitro and in Vivo
$807,165Hidde L Ploegh · Whitehead Institute For Biomedical Res · R01 · FY2011 · AI
Effect of immunization route and prior immunity for a live attenuated varicella AIDS vaccine
$807,124Vicki L Traina-Dorge · Tulane University Of Louisiana · R01 · FY2017 · AI
Targeting PD-1 Pathway for Functional Cure of AIDS
$807,098Rama Rao Amara · Emory University · R37 · FY2023 · AI
Center for Clinical and Translational Science
$807,056Robert P Kimberly · University Of Alabama At Birmingham · UL1 · FY2021 · TR
Center for the Study of Innate Immunity to HCV Infection
$807,007Michael J Gale · University Of Washington · U19 · FY2013 · AI
Polymerase Inhibitors of Respiratory Syncytial Virus
$806,958Richard K. Plemper · Georgia State University · R01 · FY2020 · AI
Fine Mechanisms of Adaptive NK Cell Formation Against HIV and SIV
$806,931Roger Keith Reeves · Duke University · R01 · FY2024 · AI
Host blood biomarkers for the diagnosis prognosis and treatment response of childhood TB
$806,919Mark Hatherill · University Of Cape Town · R01 · FY2024 · AI
Oxidation-Specific Epitope IgA in Pulmonary Fibrosis
$806,901Jeffrey Michael Sturek · University Of Virginia · R01 · FY2025 · HL
Trusted Messengers: Supporting Physicians in Promoting COVID-19 Vaccination
$806,899Kimberly Fisher · Univ Of Massachusetts Med Sch Worcester · R01 · FY2021 · MD